Wordt geladen...
Incretin-based therapies
Incretin-based therapies have established a foothold in the diabetes armamentarium through the introduction of oral dipeptidyl peptidase-4 inhibitors and the injectable class, the glucagon-like peptide-1 receptor agonists. In 2009, the American Diabetes Association and European Association for the S...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Blackwell Publishing Ltd
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3380568/ https://ncbi.nlm.nih.gov/pubmed/21707956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1753-0407.2011.00143.x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|